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Adrenalectomy ameliorates ablative nephropathy in the rat
independently of corticosterone maintenance level
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Adrenalectomy ameliorates ablative nephropathy in the rat indepen-
dently of corticosterone maintenance level. The roles of the adrenal gland
and of dietary protein level in ablative nephropathy in the rat were
examined by comparing adrenalectomized rats, replaced with corticos-
terone at low physiological (I and 2) or high physiological (3 and 4)
levels with intact rats (5 and 6). All groups were subjected to 5/6
nephrectomy and followed 12 weeks on a regular diet (2, 4 and 6) or a
reduced protein diet (1, 3 and 5). Groups 1, 2, 5 and 6 all grew at the
same rate but groups 3 and 4 grew less, though food intake was nearly
the same in all. Higher dietary protein, higher corticosterone mainte-
nance level, and the presence of intact adrenal glands all increased
proteinuria significantly. Extracellular fluid volume (82Br space) was
identical in all groups at 8 and 12 weeks, because the animals were given
a choice of water or saline to drink. Mortality was highest (50%) in
Group 6 and lowest (11%) in Group 1, but these differences were not
significant. Final inulin clearance was significantly improved by adre-
nalectomy when non-survivors were scored as having zero clearance,
but not if the analysis was limited to survivors. It was not affected by
diet or by corticosterone level. Renal histopathological scores were also
improved significantly by adrenalectomy and by protein restriction, but
were not influenced by corticosterone level. Thus adrenalectomy and
dietary protein restriction independently ameliorate ablative nephrop-
athy, but corticosterone replacement level has no effects, except on
proteinuria. The results indicate that the deleterious effects of dietary
protein on renal histopathology persist in the absence of the adrenals,
and suggest that some substance other than corticosterone produced by
the adrenal (?cortisol) plays an even greater role in the progression of
ablative nephropathy in the rat.
of chronic renal failure to humans [2], we have undertaken a
study of the progression of ablative nephropathy in adrenalec-
tomized rats in which corticosterone is replaced at low or high
physiological levels, and dietary protein is either normal or
restricted.
In non-adrenalectomized control rats subjected to renal ab-
lation, we have not attempted to measure corticosterone levels.
Quantitation of mean corticosterone levels in rats over a
12-week period is a practical impossibility. Indeed, quantitation
over a 24-hour period is extremely difficult because diurnal
variation of plasma corticosterone in the rat is 10- 20-fold [3].
Furthermore, corticosterone secretion is sensitive to many
stimuli including noise or stress. Twenty-four hour urine col-
lections for steroid assay in the rat, unlike humans, do not
provide reliable information as to mean 24-hour production
rates of glucocorticoids because corticosterone is metabolized
in rat liver and the metabolic products are excreted in the bile
[4-6].
The results point to a protective effect of adrenalectomy that
is not reversed by corticosterone replacement even at high
levels, and to an effect of dietary protein that is independent of
the adrenal gland.
Methods
Animals and their care
In a previous study [1], we suggested a role of physiological
variations in glucocorticoid production in modifying the pro-
gression of chronic renal failure. This suggestion was based on
(1) a significant correlation between urinary excretion of 17-
hydroxycorticosteroids and rate of progression in a group of
patients, and (2) evidence suggesting that ketoacid supplements
both slow progression and suppress glucocorticoid production.
Since dietary protein is known to augment glucocorticoid
production (Discussion), we also hypothesized that the putative
effect of dietary protein to accelerate progression could be
mediated by glucocorticoids.
Testing this hypothesis in patients is difficult, since glucocor-
ticoid production is hard to control as well as hard to quantitate.
Despite reservations concerning the applicability of rat models
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Male Sprague-Dawley rats weighing 180 to 200 grams were
individually placed on arrival in cages equipped with a drinking
connector and a water bottle holder. They were acclimatized
for one week to a room with controlled temperature and
humidity and a light/dark cycle of 14/10 hours. They were
allowed free access to water and divided into two diet groups
receiving 8.5% (Groups 1, 3 and 5) or 17% (Groups 2, 4 and 6)
protein. Diets were prepared by U.S. Biochemical Corporation
(Cleveland, Ohio, USA) and were isocaloric, with identical
sodium, potassium, calcium, phosphorus and vitamin content
(by wt; Table 1).
Preparation of corticosterone-cholesterol pellets
Corticosterone and cholesterol powder (Sigma Chemical
Company, St. Louis, Missouri, USA) were mixed in ratios of
10% (Groups 1 and 2) or 50% (Groups 3 and 4) corticosterone.
Aliquots of these mixtures were melted in small beakers and
poured into wells (6 mm diameter) drilled into a block of paraffin
wax. After the pellets cooled and solidified, they were removed
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Diet II
Sucrose 500 500
Corn starch 250 150
Casein (high nitrogen) 100 200
Celufil 50 50
Corn oil 50 50
AIN mineral mixture 35 35
AIN vitamin mixture 10 10
NaH2PO4' H,O 3.5 0
D,L-methionine 3 3
Choline bitartrate 2 10
NaC1 0 1.5
CaCO3 0.136 0
from the paraffin with a scalpel and gently chiseled to free
adhering wax. Each pellet weighed approximately 110 mg.
Adrenalectomy, subtotal nephrectomy and implantation of
corticosterone pellets
Bilateral adrenalectomy (Groups ito 4) and subtotal nephrec-
tomy (all groups) were performed in two stages. Anesthesia was
induced by intraperitoneal injection of sodium pentobarbital (50
mg/kg). The left adrenal gland and kidney were exposed. The
adrenal gland was removed along with a small amount of
surrounding adipose tissue, and all extrarenal branches of the
renal artery except one were ligated, The incision was closed
and the rat was allowed to recover. Ten days later the rat was
again anesthetized and the contralateral adrenal gland and
kidney were removed. A pellet of approximately 110 mg of a
fused mixture of corticosterone and cholesterol (0%, 10% or
50% corticosterone by weight) was inserted subcutaneously.
The incision was closed.
Protocol
After one week acclimatization, the rats were divided into six
groups of 11 animals each.
After adrenal and/or renal surgery, the rats were placed in
individual cages again. Both tap water (through the drinking
pipe) and 0.9% saline, provided by a water holder bottle, were
offered. Food intake was recorded every other day. One to
three rats in each group died or became ill and were removed
from the experiment during the post-operative period. Body
weight was measured weekly except the first week after the
second operation. The corticosterone pellets (in ADX rats) and
wax pellets (in adrenal-intact rats) were changed weekly under
light ether anesthesia. Twenty-four hour urine was collected at
4, 6, 8, 10 and 12 weeks for measurement of proteinuria. One ml
of blood was withdrawn from the tail vein every four weeks for
measurement of plasma corticosterone.
Extracellular fluid volume (ECFV) was measured at 8 and 12
weeks as follows. Unanesthetized rats were given 2 pCi 82Br
(Bromine-82 Radionuclide, New England Nuclear Research
Products, Buffalo, New York, USA) in 0.4 in! of 0.9% saline
intraperitoneally. Two hours later, a 0.2 ml sample of blood was
obtained from the tail vein. Fifty microliters of plasma was
counted in a Gamma counter. Bromide space was calculated as
described by Bell, Ziegler and Forbes [7]. Urinary loss of 82Br
during the two hour interval was found to be negligible.
Glomerular filtration rate (GFR) was measured at the end of
the experiment, that is, three days after last ECF measurement.
The rats were anesthetized by intraperitoneal injection of
sodium pentobarbital (50 mg/kg), tracheotomized, and placed
on a constant-temperature table; 0.5 mlIlOO g body wt of
solution containing 1 pCi/mI 14C-inulin (Amersham, Arlington
Heights, Illinois) was infused as a prime into the left femoral
vein, followed by constant infusion of the same solution via a
syringe pump at a rate of 0.02 ml/min. A 60-minute period of
constant infusion elapsed before starting to measure clearance.
Blood samples (250 gil) were obtained from the left femoral
artery at the midpoint of each clearance period. Urine was
collected via a polyethylene tube inserted into the proximal
ureter. '4C-inulin activity was determined in 50 jsl samples of
urine or plasma added to 16 ml of scintillation cocktail (Packard
3a70B). Three clearance periods, lasting 20 minutes each, were
performed in each rat and the results were averaged. Mean
arterial pressure (MAP) was monitored throughout the experi-
ments, using a strain gauge and a Grass recorder.
Analyses
Plasma corticosterone levels (Groups 1 to 4 only) were
measured by radioimmunoassay on heat-denatured plasma
samples, using a kit (Radioassay System Laboratories, Immu-
nochem Corp., Carson, California, USA). For reasons given in
the introduction, we did not attempt to assess plasma corticos-
terone in Groups 5 and 6.
Urine protein was measured by Peterson's modification [8] of
the micro-Lowry method [9], in which sodium dodecylsulfate is
added to the Lowry reagent to facilitate the dissolution of
relatively insoluble lipoproteins, using a kit (Sigma Diagnostics
procedure No. P5656).
In order to obtain normal values for proteinuria and ECF,
nine normal rats were allowed free access to 17% protein and
both water and 0.9% saline for three weeks. Twenty-four hour
urine was collected. ECF was measured as above. Normal
values for GFR and MAP were determined in six normal rats
fed a 14% protein standard diet and water ad libitum for one
week.
Morphologic studies
Kidneys were sectioned in thirds and fixed in neutral buffered
formalin. The sections were paraffin-embedded for light micros-
copy. Routine stains included hematoxylin and eosin, periodic
acid-Schiff, and a combination Gomori methenamine silver-
Masson-Ponceau stain, for basement membranes and connec-
tive tissue elements.
Histology was evaluated blindly. The frequency of glomeru-
lar lesions was determined by evaluating all glomerular profiles
in a coronal section (except those in areas rendered ischemic or
infarcted by the vascular ligation). Glomeruli were grouped in
three categories: (1) Normal: Fully expanded, with patent
capillary loops, delicate capillary walls and no capsular adhe-
sion. (2) Segmental sclerosis: Areas of capillary collapse and
sclerosis, usually with capsular adhesion, and often with focal
hyalinosis in distended capillary loops. A portion of glomerulus
remains intact with open capillary loops, with or without
mesangial expansion. (3) Global sclerosis: Collapse and/or
occlusion of majority of glomerular tuft, with more than 90% of
capillary lumens occluded.
In addition, the following renal lesions were evaluated:
Table 1. Composition of diets, g/kg
Diet I
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Table 2. Effect of corticosterone and dietary protein on food intake,
g/100 g/body wt following adrenalectomy plus renal ablation
Group
Weeks
4 6 8 10 12
2
3
4
5
6
544
5.08k
5.60a
5.29a
5.69a
5.18a
54
494a,b53I
5.OT'
5.04a
456b
44a,b
447a.b
4.87a
4.69
430b
372b
4.62a
464
4.66a
43Q
4.l1
449
4.51a
4.l5a
473
444
3.82a
389
Means in each column lacking a common letter in the superscript are
signficantly different (P < 0.05)
Tubular basophilia, tubular atrophy, tubular dilatation, intersti-
tial inflammation, interstitial fibrosis, and arterial and arteriolar
lesions. A semiquantitative scale, 0 to 4+, was employed to
indicate the extent and/or severity of these lesions.
Calculations
Results are shown as means SD.
One-way analysis of variance was used to determine the
significance of differences between means of the experimental
groups for food intake and growth because these data appeared
to be normally distributed. In the case of mortality, chi-square
was used. The effects of diet protein level, adrenalectomy and
(within adrenalectornized animals) of low versus high corticos-
terone maintenance level were examined by the Wilcoxon test,
with a continuity correction, because these data appeared not to
be distributed normally. We used SAS software (SAS Institute,
Cary, North Carolina, USA) for these calculations.
Results
Plasma corticosterone
In Groups 1 and 2, final plasma corticosterone levels were
4.14 0.85 sg/dl and 3.20 1.54 sgIdl, respectively, differing
insignificantly. In Groups 3 and 4, plasma corticosterone levels
were 11.00 2.79 and 11.10 2.44 tg/dl, also not differing
from one another but significantly higher than in Groups I and
2. Thus the first two groups were maintained at a low normal or
slightly subnormal level of corticosterone, while the second two
groups were maintained at a high level, beyond the upper limit
of mean 24-hour corticosterone concentration in normal rats
[10]. We have documented elsewhere [11] that diurnal variation
of plasma corticosterone levels is eliminated in pelletized adre-
nalectomized rats, and that constant levels are maintained when
pellets are replaced weekly [12].
Food intake and weight gain
As shown in Table 2, food intake was nearly the same in all
six groups, but fell progressively when expressed per 100 g of
body weight, as expected in rapidly growing animals. During
weeks 6 to 8, intact rats tended to consume less food than
adrenalectomized rats, but no differences were apparent at
other times. Weight gain is depicted in Figure 1 and the
significance of the differences indicated in Table 3. Groups 3
and 4, maintained at a high level of corticosterone, gained
weight less rapidly than the other groups despite equal food
intake. This is consistent with our findings in non-nephrecto-
mized adrenalectomized rats [12]. In the present study, adre-
nalectomized rats maintained at a low level of corticosterone (3
to 4 sg/dl) gained weight normally. Previously we found that
maintenance at a somewhat higher level of corticosterone (5 to
7 ttgIdl) led to faster than normal weight gain, perhaps because
the extremes of the normal diurnal fluctuation in plasma corti-
costerone levels were avoided [12].
Mortality
As shown in Table 4, mortality rate in the various groups
varied from 11% to 50%, being highest in Group 6. However,
these differences were not statistically significant.
Extracellular fluid volume and blood pressure
As shown in Tables 4 and 7, extracellular fluid volume as a
fraction of body weight was remarkably constant, although
somewhat higher than in normal rats (26.6 1.6%, N = 9).
Nevertheless, final MAP was reduced by protein restriction but
was unaffected by adrenalectomy or corticosterone mainte-
nance level. In normal rats, MAP was 98 9 mm Hg (N =6).
These results appear to indicate that dietary protein increases
blood pressure in this rat model by a mechanism independent of
extracellular fluid volume or the adrenal gland. However, as
noted below, this finding may be secondary to an effect of
dietary protein level on renal injury. Furthermore, we were able
to measure MAP only at the end of the experiment, in anesthe-
tized animals, which may have affected the results.
Proteinuria
Figure 2 depicts sequential changes in 24-hour protein excre-
tion. The significance of these differences is given in Table 7.
In normal rats, proteinuria averaged 10.0 2.6 mglday/100 g
body wt (N 9). In Group I, proteinuria remained at this level.
In the other five groups, proteinuria increased progressively.
By far the greatest increase was seen in Group 6. Dietary
protein level, corticosterone level, and the presence of the
adrenals all increase proteinuria significantly at almost every
time interval examined.
Renal function
Final mean GFRs are given in Table S and tests for signifi-
cance in Table 7. Similar results, but without statistical signif-
icance, are seen if this analysis is limited to surviving animals
rather than scoring dead animals as having zero GFR. How-
ever, there seems little reason to doubt that renal failure was the
predominant cause of mortality (Table 4). Lowest GFR is seen
in Group 6, while highest GFR is seen in Group 1. Normal rats
exhibited a mean GFR of 2.87 0.37 mI/mm (N = 6). GFR was
negatively correlated with MAP (r = —0.49, P = 0.003). Neither
dietary protein level nor corticosterone maintenance level (in
adrenalectomized rats) affected GFR significantly, but adrenal-
ectomy led to a significant doubling of GFR.
Renal histopathology
Mean scores in each group for three of the parameters are
shown in Table 6; the other seven parameters are omitted to
conserve space; in Table 7 are shown the results of statistical
analysis of the separate effects of dietary protein level, adre-
nalectomy, and (in adrenalectornized rats) of corticosterone
maintenance level. Corticosterone level had no significant effect
-c
>-
-o0
Table 3. Effect of corticosterone and dietary protein on weight gain
following adrenalectomy plus renal ablation
Group
Initial
wt,g
Cumulative weight gain at each week, g
2 4 6 8 10 12
I 29O 38b,c 71b 3a l28 146a 160a
2 280 39b,c 80a.b 145k 178 19?
3 290 l9C 29C 42b 64b 82b 92b
4 294k l6C 47b 6l' 79b 100b
5 296 7Ø 84,b 11? l23 163 172
6 293 52a,b lO4 123 139 I46 l49
Means in each column lacking a common letter in the superscript are
significantly different (P < 0.05)
on glomerular, tubular, or interstitial histology. Higher dietary
protein significantly increased several parameters, including
segmental glomerulosclerosis, mesangial thickening, tubular
basophilia and dilatation, and interstitial inflammation and
fibrosis. Significant improvement in 8 of 10 histopathological
scores was induced by adrenalectomy. Thus this variable had
the greatest effect on outcome.
Discussion
These data show that the deleterious effects of dietary protein
are, for the most part, as pronounced in adrenalectomized
animals as in adrenal-intact animals. However, few differences
were observed between adrenalectomized rats maintained at a
high level of corticosterone and those maintained at a low level.
Thus it is clear that corticosterone does not mediate the
deleterious actions of dietary protein in this model of chronic
renal failure.
On the other hand, an unexpected effect of adrenalectomy
was demonstrated. Intact rats fared worse than adrenalecto-
mized rats in almost every respect, whether fed a regular or
restricted protein diet. Intact rats had higher mortality, higher
blood pressure and greater proteinuria (although these changes
were not significant), more severely reduced renal function and
more severe histopathological changes in the kidney (these
were all significant). Clearly adrenalectomy provides a marked
degree of protection against ablative nephropathy, independent
of corticosterone maintenance level.
This unexpected finding provokes a re-examination of the
evidence that led to the original hypothesis.
The first indication that endogenous glucocorticoid produc-
tion is correlated with rate of progression of chronic renal
failure came from observations of patients being followed with
sequential radioisotope GFRs, most of whom were undergoing
dietary therapy and receiving supplements of either essential
amino acids or ketoacids (1). Highly significant correlations
were noted between rate of progression, y, estimated from the
least squares linear regression of GFR on time in months, and
urinary 17-hydroxycorticosteroid excretion (17OHCS) in all
three groups of patients.
Multiple stepwise regression also identified 17OHCS as an
important predictor of y (1). Weighted multiple stepwise linear
regression was found to yield essentially the same results [131.
Furthermore, ketoacid supplementation in comparison with
amino acid supplementation (without change in diet) reduced
I7OHCS and reduced y [1]. More recently, y has also been
shown to be correlated with urinary excretion of free cortisol
[14]. This finding makes it unlikely that the correlation observed
between y and 17OHCS is a reflection of altered glucocorticoid
metabolism rather than altered glucocorticoid production.
It has long been known that exogenous steroids may cause renal
lesions under some circumstances [15]. In rats subjected to
subtotal nephrectomy, methyl-prednisolone accelerates the devel-
opment of proteinuria and glomeruloscierosis, perhaps by increas-
ing glomerular capillary pressure, since this effect is prevented by
simultaneous angiotensin converting enzyme inhibition [16]. Glu-
cocorticoids augment proteinuria in the nephrotic syndrome [17—
19]. As first shown by Addis et al [20] adrenalectomy reduces or
obliterates proteinuria in response to renin, angiotensin and other
maneuvers and corticosterone replacement restores it [2 1—23].
A role of glucocorticoids in mediating the deleterious effect of
500
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Fig. 1. Weight gain during the 12 week study.
Adrenalectomized rats replaced with high
dose corticosterone (triangles) gain less
rapidly than other groups.
0 2 4
Time, weeks
8 10
330 Quan et al: Ablative nephropathy in adrenalectomized rats
Table 4. Effect of corticosterone and dietary protein on mortality, mean arterial pressure and extracellular fluid volume following
adrenalectomy plus renal ablation
Group and Diet Mortality ECF/body wt, °' Final MAP
(N) protein Cort.a Deaths % 8 weeks 12 weeks mm Hg
1(10) Low Low 2 20 31.2 3.2 32.1 2.3 87 13
2(9) Regular Low 1 11 32.7 3.9 31.2 1.8 107 12
3 (9) Low High 3 33 32.2 5.1 32.2 3.1 93 9
4(9) Regular High 3 33 31.7 2.4 30.5 3.4 114 11
5 (8) Low Intact 3 37.5 30.9 4.8 31.8 4.2 97 12
6(10) Regular Intact 5 50 31.6 3.6 32.0 4.9 128 12
a Corticosterone maintenance level
Table 5. Effects of corticosterone and dietary protein on proteinuria following adrenalectomy plus renal ablation
Group and Diet Proteinuria, mg/day/100 g body wt Final GFR Final GFR2'
(N) protein Cort.a 4 weeks 6 weeks 8 weeks 10 weeks 12 weeks dIminhl00 g body wt
1(10) Low Low 12.9 20.5 9.1 7.8 10.0 10.0 10.5 10.3 11.6 10,0 74 70 96 64
2 (9) Regular Low 10.6 2.4 12.6 8.2 18.4 16.1 26.3 19.3 35.6 21.2 42 36 56 30
3 (9) Low High 15.3 9.1 19.4 19.3 21.2 20.3 35.7 33.6 29.7 15.6 69 73 92 71
4(9) Regular High 28.5 18.8 41.4 24.2 41.8 26.5 46.4 20.3 51.0 30.9 53 64 79 64
5 (8) Low Intact 19.1 12.8 49.4 39.9 34.7 24.4 38.5 30.9 42.4 28.9 49 56 79 50
6 (10) Regular Intact 27.8 7.7 50.0 16.1 64.7 21.3 79.3 28.8 95.2 30.5 10 15 26 15
a Corticosterone maintenance levelb GFR1 mean GFR scoring dead animals as GFR = 0; GFR2 mean GFR of survivors only
Group and
(N)
Diet
protein Cort.a
Tubular
dilatationGlobal Segmental
1(10) Low Low 0.3 0.7 11.0 8.1 0.52 0.44
2 (9) Regular Low 2.8 3.2 34.3 22.6 1.61 0.74
3 (9) Low High 6.6 12.6 26.3 22.5 1.29 1.41
4 (9) Regular High 4.5 6.8 37.6 18.4 1.90 1.05
5 (8) Low Intact 24.9 22.4 33.1 19.5 2.40 1.43
6 (10) Regular Intact 23.8 24.9 44.3 13.9 2.39 0.74
and metabolism, two reports have documented high morning
0 4 6 8 10 12 levels of free cortisol in plasma of adults with CRF [32—33].
Corticosteroid-binding globulin exhibits normal binding affinity
Time, weeks and capacity for cortisol in uremic plasma [34], but cortisol
binding to albumin is decreased [35]. In non-dialyzed uremic
adults, the urinary excretion of corticoid metabolites was
reported to be 65% of normal [36]. Cortisol metabolism is
delayed in uremic subjects [37—40]. In uremics, corticotropin-
ADX+ Lowcort 0 •
ADX + High cort. A
Intact *
releasing hormone leads to a subnormal response of plasma
ACTH [41, 42].
Although these observations, considered in toto, establish a
role of glucocorticoids in proteinuria and establish that gluco-
corticoid production is responsive to protein intake, the corre-
lations seen between progression and glucocorticoid levels do
not prove causality. Thus it is conceivable that some other
hormone or mediator, whose production is correlated with
glucocorticoid production, is responsible for accelerating pro-
gression. The reported association between rate of progression
of chronic renal failure and proteinuria [43, 44] may also be
attributable to a correlation between glucocorticoid production,
which clearly augments proteinuria, and the rate of production
E
C
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Table 6. Effects of corticosterone and dietary protein on selected
renal histopathological scores after adrenelectomy plus renal ablation
Glomerulosclerosis
a Corticosterone maintenance level
Fig. 2. Proteinuria as a function of time after subtotal nephrectomy in
each group. Intact rats on a regular protein diet exhibit the greatest rise
in proteinuria. Symbols are:
Diet Protein
Low Regular
protein intake on progression was suggested by the observa-
tions that protein intake augments cortisol production in hu-
mans [24—28] and corticosterone production in rats [29, 30].
Furthermore, protein-restricted diets reduce cortisol levels
[311.
As to the effects of renal failure on glucocorticoid production
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Table 7. Results of non-parametric statistical analysis of the separate effects of diet protein level, adrenalectomy, and corticosterone
maintenance level on proteinuria, ECF, GFR, MAP, and renal histopathology
Groups
Level
Diet
1,3
Low
protein
2,4
High
Adrenal
1,2,3,4
Yes
ectomy
5,6
No
Cortic
1,2
Low
osterone
3,4
High
Inulin clearance, pJ/min/100 g body wt, scoring dead rats as zero 34 65 60 28 59 60
Inulin clearance, pJ/min/lO0 g body wt, survivors only 90 57 81 55 77 86
Extracellular fluid volume, % body wI, 8 weeks 31.4 32.0 31.9 31.5 31.9 31.9
Extracellular fluid volume, % body wt, 12 weeks 32.0 31.2 31.3 31.9 31.7 31.2
Mean arterial pressure, mm Hg 92' 14b 100 Ill 97 104
Proteinuria, mg/day, week4 155b 225b l6.7c 24.0c 11•8d 219d
Proteinuria, mg/day, week 6 23.7a 34•9a 19•7b 497b 10.8c 30.3
Proteinuria, mg/day, weekS 20.0 4Ø7 220b 518b l4.Oe 31.6e
Proteinuria, mg/day, week 10 26.3a 48.2a 290b 608b 18.4c 41.lc
Proteinuria, mg/day, week 12 254b 562b 30.8c 68.8c 23.6 40.3
Global glomeruloscierosis, % 9.7 10.6 33b 242b 1.6 5.5
Segmental glomerulosclerosis, % 224b 388b 27. ia 39•4a 22.7 32.3
Normal glomeruli, % 67.9a 50.6a 69•6b 363b 75.8 62.2
Mesangial increase, score (0—4) 0.42a 0.67a 0.48 0.70 0.43 0.55
Tubular basophilia, score (0—4) 112b 201b 1.45 1.88 1.40 1.51
Tubular atrophy, score (0—4) 1.06 1.32 l.04a 1.53a 0.91 1.20
Tubular dilatation, score (0—4) l.33a l.97a l.32' 2.39l 1.07 1.61
Interstitial inflammation, score (0—4) 0.92 1 .35 1 .00 I .45 0.88 1.13
Interstitial fibrosis, score (0—4) 0.41a Ø•73a 0•39b 097b 0.32 0.48
Arterial lesions, score (0—4) 0.83 0.98 0.49k' 178b 0.28 0.73
a,e < 0.05
b,c,d P < 0.01
of some other substance that mediates progressive renal injury
or inhibits healing of renal lesions.
The present results dissociate proteinuria and glucocorticoid
maintenance level from progression of renal injury. Corticos-
terone maintenance level had a major effect on proteinuria but
no effect on renal injury, as measured by final inulin clearance,
incidence of glomeruloscierosis, tubular lesions, or interstitial
abnormalities.
If adrenalectomy protects in some way other than reducing
corticosterone levels, several possibilities come to mind.
First, mineralocorticoids could play a role. In this study,
mineralocorticoid replacement was not provided, and we relied
on salt appetite to maintain extracellular fluid volume, with
apparent success. The possibility that aldosterone mediates
renal injury seems improbable but warrants further investiga-
tion. If so, spironolactone should be useful in slowing progres-
sion, and severe salt restriction might accelerate progression.
No data are available to answer these questions. Aldosterone
exerts extrarenal effects, for example, on blood pressure [45],
However, Bauman [23] found that aldosterone, unlike dexa-
methasone, did not restore the proteinuric response to angio-
tensin II or norepinephrine in adrenalectomized rats.
Sodium intake from the diet was constant because NaCI
replaced Na2HPO4 (Table 1). Ingestion of saline, however, was
not monitored and may well have varied between groups.
Differences in extracellular fluid volume could not have medi-
ated any possible effects of salt intake on renal injury, because
as noted in Table 4, extracellular fluid volume was remarkably
constant. Nevertheless, it is conceivable that differences in salt
intake and excretion could have been responsible, perhaps by
affecting renal oxygen consumption or cell growth.
Second, adrenal androgens could play a role. There appears
to be little evidence to support this possibility one way or the
other. Androgens induce renal hypertrophy, especially of the
proximal tubules [46]. Conceivably, different results would
have been found if we had performed this study in female rats.
Third, catecholamines secreted by the adrenal medulla could
mediate progression. Circulating levels of epinephrine (but not
norepinephrine) are markedly reduced by adrenalectomy [47].
If beta-adrenergic stimulation contributes to progression, beta-
blockers should slow progression. There does not appear to be
any evidence to support this possibility.
A final possibility, which we favor, is that 17-hydroxygluco-
corticoids, but not corticosterone, play a role in progression by
inhibiting healing of renal injury. Although corticosterone is the
predominant circulating glucocorticoid in the rat, isolated rat
adrenals produce both cortisol and corticosterone [48]. Repeti-
tion of the present studies using cortisol instead of corticoster-
one as replacement would be of interest.
The role of hypertension, either systemic or glomerular, in
mediating renal injury in this study is conjectural. We cannot
ascertain whether the correlation between injury and final mean
arterial pressure observed reflects cause or effect. It is of
interest, however, that there was no correlation between final
mean arterial pressure and extracellular fluid volume. Thus, if
hypertension caused renal injury, rather than being the result of
renal injury, both protein restriction and adrenalectomy inde-
pendently reduced blood pressure even though neither altered
extracellular fluid volume. This seems improbable. We consider
it more likely that the changes in final blood pressure were
secondary to variations in the severity of renal injury.
Previous workers have found no effect of protein restriction
on blood pressure of rats with remnant kidneys [49]. Whether
the difference between our findings (Tables 4 and 7) and these
previous results is methodological is uncertain. Since we were
only able to measure blood pressure once, during anesthesia, it
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is possible that different responses of blood pressure to anes-
thesia between adrenalectomized and intact rats may account
for our findings.
The mechanism by which dietary protein restriction amelio-
rates ablative nephropathy is not revealed by this work. All of
the beneficial effects of dietary protein restriction were compa-
rable in magnitude in adrenalectomized and intact rats. Hence,
reduced secretion of adrenocortical steroids is excluded as an
explanation. The report [30] that dietary protein level affects
glucocorticoid production in rats, including urinary excretion of
Porter-Silber-measured corticosteroids, casts some doubt on
our reformulated hypothesis: namely, that dietary protein ag-
gravates renal injury by stimulating 17-hydroxycorticosteroid
production. However, the substances measured in rat urine by
the method used in this earlier study [30] may not be 17-
hydroxycorticosteroids [50]. Clearly, further work is needed to
clarify these questions.
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